The $1 Trillion Chasm Between Goldman Sachs and Morgan Stanley on SpaceX — How to Track SPCX Through the Noise

SPCX by the Numbers, Two and a Half Weeks After the Quiet Period

The IPO raised roughly $86 billion once underwriters exercised the greenshoe option, making it the largest public offering ever, ahead of every Saudi Aramco record and every Alibaba reopening. The free float was waived from the typical 10% to about 5% under a special Nasdaq rule change in March 2026, which is one of the structural reasons the stock traded above $200 within days of listing.

Why a Trillion-Dollar Disagreement Is Noteworthy

Two banks co-led the same deal, ran the same due diligence on the same cap table, and then published numbers that disagree by an order of magnitude. Goldman Sachs came out with a model that sees SpaceX generating roughly $474 billion in revenue by 2030 — driven primarily by Starlink's consumer broadband and enterprise mobility businesses plus a steady ramp in launch cadence. Morgan Stanley sees a slower 2030 (around $330 billion in revenue) but pushes the terminal value into 2040, where it pencils in $3.4 trillion in annual revenue across Starship cargo, orbital data centers, and Starlink Direct-to-Cell services.

Discounted back to today, the Morgan Stanley terminal value implies an enterprise value of more than a trillion dollars above Goldman's 2030-only model. That is the chasm. Independent voices have lined up across the spread: Morningstar pegged fair value around $780 billion, NYU's Aswath Damodaran published an enterprise value near $1.3 trillion, and short-seller Michael Burry was blunt enough to say that nothing in the S-1 suggests it is worth $1 trillion, let alone $2 trillion. Jim Chanos called the offering a don't-look-at-the-man-behind-the-curtain situation, and FT columnist Robin Wigglesworth noted that when you see an IPO give a far larger allocation to ordinary investors, it's usually a sign that they can't get professional investors to buy it at that price.

When two of the most sophisticated banks on Wall Street publish terminal values that disagree by more than the entire market cap of every S&P 500 company outside the top ten, retail investors should not be pretending they have a view. The honest position is to size SPCX modestly, mark it to market every day, and let the next four quarters of actual earnings resolve the question.

What Index Inclusion Means for Your Portfolio Tomorrow

SpaceX was fast-tracked into the Nasdaq-100 on the back of a March 2026 Nasdaq rule change that shortened the listing-history requirement to 15 trading days. That decision forces every Nasdaq-100 tracking fund — including the QQQ ETF — to start buying SPCX on a known schedule. Published estimates put incremental passive demand between $30 and $50 billion, against a tradable float of roughly $50 to $75 billion. That is a structurally tight setup regardless of whether Goldman or Morgan Stanley turns out to be closer to right.

Translation for the average investor: if you hold QQQ, VGT, any Nasdaq-100 ETF, or a tech-tilted S&P 500 fund, you already own SPCX. The exposure is invisible in every brokerage app you log into, the position lives inside an index wrapper that does not break out individual constituents, and you have no way to know what your cost basis effectively is. Even investors who bought SPCX directly on day one are sitting on top of an indirect allocation through index funds that compounds the bet without their consent.

There is only one way to know your real exposure: stop trusting the index wrappers and pull the underlying constituent exposure into the same sheet as your direct holdings. A custom SUMIF across the InvestSheet holdings tab gives you a defensible read on what SPCX really represents in your total book.

A Retail SPCX Dashboard, Built From Real Brokerage Data

Imagine an investor who bought 50 shares of SPCX at the IPO, holds QQQ in a separate Fidelity account, and has a tech-sector ETF in a Roth IRA at Schwab. None of the three brokerage apps will tell them that the entire position is now a bet on whether Goldman's $474 billion 2030 revenue or Morgan Stanley's $3.4 trillion 2040 revenue scenario is closer to reality. Here is what the consolidated view looks like in one sheet:

The direct SPCX line is honest: 50 shares at a $135 cost basis. The QQQ and VGT lines hide roughly a 4% allocation to SPCX inside each wrapper, on top of the direct position. That is a triple-counted bet that no brokerage app surfaces and no model portfolio on the internet warns you about.

Discipline When the Models Disagree by a Trillion Dollars

Treat any direct SPCX position as a venture-style allocation, not a core holding. Cap the direct line at 1–2% of total invested assets. Mark the indirect exposure through QQQ and VGT at roughly the published index weight (about 4% of QQQ at the moment), then decide whether the combined direct + indirect bet crosses your personal risk threshold. Most investors who already held QQQ before the IPO have crossed it without noticing.

Watch the next two earnings prints closely. The Q2 2026 report drops in late July and will be the first real read on whether the Starlink ramp is on Goldman's curve or Morgan Stanley's. The Q3 number will tell you whether the post-IPO bond issuance ($25 billion across five tranches at 5.35–6.65% coupons, oversubscribed three times) is feeding revenue growth or just refilling the cash drawer.

Whatever number you settle on, write it down. The whole point of having every brokerage in one sheet is to be able to look back next quarter and see whether your actual exposure matched the exposure you thought you had.

Frequently Asked Questions